Novo Nordisk Donates Compound Library to Chinese Pharmaceutical Development and WHO

Novo Nordisk A/S has announced a scientific collaboration that will benefit both Chinese pharmaceutical development and WHO efforts to combat neglected diseases. Novo Nordisk will donate a licence to its small molecule compound library to the National Center for Drug Screening affiliated to Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The centre will use the library - both the actual compounds and an associated database - for screening activities to identify new drug candidates for infectious tropical diseases that affect people in poor countries.

The World Health Organization-based Special Programme for Research and Training in Tropical Diseases will select targets and screens to support the identification of new drug candidates or leads for infectious tropical diseases, including malaria, tuberculosis, African sleeping sickness, dengue, Chagas disease, leishmaniasis, schistosomiasis, filariasis, onchocerciasis and soil-transmitted helminths. It will also bring in young scientists from developing countries, especially Africa, to be trained at the institute.

For further information please contact:

Elin K. Hansen,

Media Relations

Tel: +45 44 42 34 50

Email: ekh@novonordisk.com

Or visit: www.novonordisk.com